iFabric (IFA) AI Stock Analysis

• Market Cap: C$93.32M
• Dividend Yield: N/A
• Average Volume (3M): 9.50K
• Price to Earnings (P/E): 17.8
• Beta (1Y): -0.11
• Revenue Growth: 41.93%
• EPS Growth: N/A
• Country: CA
• Employees: 36
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Apparel - Manufacturers
• EPS (TTM): 0.02
• Shares Outstanding: 30,299,467
• 10 Day Avg. Volume: 14,356
• 30 Day Avg. Volume: 9,500
• PEG Ratio: -6.05
• Price to Book (P/B): 1.82
• Price to Sales (P/S): 1.20
• P/FCF Ratio: -7.18
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 61 Neutral
• Price Target: C$3.00 ▲(60.43% Upside)
• Action: Reiterated Date: 03/17/26
• Date: Action: Reiterated 03/17/26

The score is driven primarily by mixed financial performance: strong revenue growth and low leverage are tempered by deeply negative TTM operating/free cash flow, which is the key risk. Technicals show a clear uptrend but with overbought signals that can increase short-term pullback risk. Valuation appears reasonable at a ~17.8 P/E, with no dividend data to add support.

Positive Factors

Proprietary Intelliflex technology

Owning the Intelliflex platform provides a durable product differentiation and technical moat: built-in antimicrobial, UV and cooling/wicking capabilities can support licensing, OEM treatments and branded product margins, enabling recurring revenue streams if adoption scales.

Consistent revenue growth

Sustained TTM top-line growth indicates expanding commercial traction for treated fabrics and apparel. Persistent revenue expansion supports operational scaling, improves fixed-cost absorption, and underpins longer-term margin recovery if the company sustains product adoption.

Low leverage / strong balance-sheet flexibility

Very low debt provides financial flexibility to fund commercialization, R&D or inventory build without heavy interest burdens. This reduces insolvency risk and gives management runway to execute strategic initiatives despite near-term cash-flow variability.

Negative Factors

Deep negative operating and free cash flow

Sustained cash burn undermines the firm's ability to self-fund growth or absorb working-capital swings; it increases reliance on external financing, can dilute shareholders, and constrains investment in sales, distribution, or product development until cash conversion reverses.

Inconsistent profitability and past losses

Intermittent profitability and historical loss years signal earnings volatility. This reduces predictability of free cash flow and weakens the case for stable reinvestment or dividend policy, complicating long-term planning and investor confidence.

Commercialization and adoption risk

Revenue depends on third-party adoption and effective distribution of treated fabrics; slow OEM/brand uptake or execution missteps could constrain scale. Structural reliance on partners makes growth contingent on proving repeatable, scalable commercial models.

iFabric Business Overview & Revenue Model

Company Description

iFabric Corp. designs and distributes women's intimate apparel and accessories in Canada, the United States, the United Kingdom, Southeast Asia, and internationally. The company's Intimate Apparel division engages in the design, purchase, and distribution of intimate apparel, which includes a range of specialty bras, including reversible bra, patented bandeaux bra, and patented breast lift products. Its Intelligent Fabrics division engages in development, testing, and distribution of specialty textiles and chemicals for textiles, such as Protx2, an anti-microbial and anti-viral formulations; Enguard, an insect repellant technology; Dreamskin, a skin polymer; UVtx, an ultraviolet light blocker; FreshTx, an odor absorbing technology; RepelTX, a durable water repellant; Omega+, a joint and muscle recovery; TempTx, a thermal regulator; Apollo, a body odor neutralizer; DryTx, a moisture-wicking technology; BioTX, a metal free anti-stink solution; RepelTX Eco Plus, a fluorine-free durable water repellant; IMPRINT, a logo exposing moisture-wicker; and DriForce, a fabric interior moisture wicker. iFabric Corp. was founded in 1985 and is headquartered in Markham, Canada.

How the Company Makes Money

iFabric makes money primarily by commercializing its proprietary fabric-treatment technologies and selling treated apparel/textile products. Key revenue streams include: (1) Product sales: revenue from selling apparel and textile items that incorporate its treatments (including, where applicable, branded products such as Coconut Cloud™). This typically includes wholesale/retail sales channels depending on the product line and distribution approach in a given period. (2) Technology commercialization: revenue from providing its Intelliflex™ treatments to third parties, which can include supplying treated materials and/or charging for the application of treatments to fabrics used in partners’ products. (3) Licensing/royalties and collaboration income: to the extent iFabric enters agreements allowing other companies to use its proprietary treatments, it may earn licensing fees and/or royalties based on sales of partners’ products; specific partnership details and the materiality of this stream are null. Significant factors affecting earnings generally include the adoption rate of its fabric treatments by brands and manufacturers, the scale and repeat nature of orders for treated textiles/apparel, and the company’s ability to maintain proprietary differentiation and execute distribution for any owned apparel brands.

iFabric Financial Statement Overview

Summary

Strong TTM revenue growth (+17.1%) and positive profitability (about 40.5% gross margin, 5.3% net margin) are supported by a low-leverage balance sheet (debt-to-equity ~0.08). The major offset is sharply negative TTM operating and free cash flow (about -$5.2M and -$5.4M), indicating weak cash conversion and higher earnings volatility risk.

Income Statement

TTM (Trailing-Twelve-Months) revenue growth is strong (+17.1%), and profitability is positive with a ~40.5% gross margin and ~5.3% net margin. However, profitability remains modest versus the revenue base, and margins have compressed versus 2024 (net margin ~6.0%) and are well below 2021 levels, highlighting ongoing earnings volatility across the cycle.

Balance Sheet

Leverage is low with debt-to-equity around 0.08 in the most recent periods, providing balance-sheet flexibility and limiting financial risk. Equity is sizable relative to assets, and returns on equity are positive in TTM (~4.9%), but have been inconsistent over time (loss years in 2022–2023), suggesting profitability durability is still improving rather than fully established.

Cash Flow

Cash generation is the key weakness: TTM (Trailing-Twelve-Months) operating cash flow and free cash flow are deeply negative (about -$5.2M and -$5.4M, respectively), a sharp reversal from positive cash flow in 2023–2024. While reported free cash flow growth looks unusually high, the current-period cash burn raises concerns about working-capital swings and the ability to consistently convert earnings into cash.

Breakdown	Sep 2025	Mar 2025	Sep 2023	Sep 2022	Sep 2021
Income Statement
Total Revenue	32.39M	27.33M	22.72M	19.74M	19.76M
Gross Profit	11.71M	11.27M	8.84M	7.03M	7.76M
EBITDA	2.39M	2.11M	-2.26M	-27.09K	3.21M
Net Income	1.57M	1.63M	-1.69M	-452.46K	2.37M
Balance Sheet
Total Assets	30.56M	29.49M	25.91M	27.37M	27.63M
Cash, Cash Equivalents and Short-Term Investments	1.23M	2.06M	1.57M	944.73K	8.90M
Total Debt	6.40M	1.88M	2.03M	1.24M	1.27M
Total Liabilities	9.26M	6.35M	5.21M	4.60M	5.35M
Stockholders Equity	21.30M	23.13M	20.69M	22.75M	22.27M
Cash Flow
Free Cash Flow	-5.40M	208.92K	644.99K	-8.45M	-2.48M
Operating Cash Flow	-5.16M	301.78K	833.77K	-8.21M	-2.22M
Investing Cash Flow	-247.06K	-52.86K	-138.38K	-242.76K	-253.40K
Financing Cash Flow	2.35M	-214.74K	-14.42K	41.93K	10.46M

iFabric Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1.87
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IFA, the sentiment is Positive. The current price of 1.87 is below the 20-day moving average (MA) of 2.10, below the 50-day MA of 2.01, and above the 200-day MA of 1.36, indicating a bullish trend. The MACD of 0.14 indicates Negative momentum. The RSI at 82.24 is Negative, neither overbought nor oversold. The STOCH value of 92.75 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:IFA.

iFabric Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MENE	62 Neutral	C$48.24M	176.66	-8.97%	―	18.89%	-19.61%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
IFA	61 Neutral	C$93.32M	17.83	7.30%	―	41.93%	―
GOOS	57 Neutral	C$1.44B	3.20	4.23%	―	3.78%	-54.87%
RET	55 Neutral	C$101.19M	30.61	-0.06%	―	-1.95%	-102.54%
UNI	55 Neutral	C$32.32M	9.24	12.40%	―	-5.96%	―
ROOT	54 Neutral	C$134.50M	14.11	-19.60%	―	4.87%	-1195.39%

iFabric Corporate Events

iFabric Projects Record 2025 Revenue and Transformative Growth in 2026

iFabric Corp. estimates fiscal 2025 revenue at about $33 million, a 20% year-over-year increase and a new annual record, while projecting first-quarter 2026 revenue between $20 million and $25 million, which would mark the largest quarter in its history. Management attributes this acceleration to rapid growth in clinically proven medical scrubs programs, broader retail reach and Intelligent Fabric Technologies’ expansion into new product categories, which together are expected to drive continued growth through 2026 and 2027.

The company is also reshaping its intimate apparel business by transitioning away from its former Maidenform license and replacing that revenue with its own brand platform aimed at a younger, better-aligned demographic. This shift, combined with short-term inventory clearance support to help major retailers migrate from competing brands to iFabric-branded programs, is intended to create wider long-term opportunities in product development, market positioning and channel expansion, underscoring a strategic move toward higher-margin, company-owned brands.

The most recent analyst rating on (TSE:IFA) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on iFabric stock, see the TSE:IFA Stock Forecast page.

iFabric’s Doctor’s Choice Medical Scrubs Win 1,000-Store U.S. Retail Expansion

iFabric Corp.’s subsidiary Intelligent Fabric Technologies (North America) has secured a 1,000-store expansion for its Doctor’s Choice scrubs at a major U.S. national big-box retailer, following an initial rollout that moved from online to in-store channels in late 2025. The company says this enlarged footprint signals retailer confidence in the brand, strong consumer uptake, and recognition of the performance benefits delivered by its proprietary textile technologies.

Doctor’s Choice scrubs combine comfort and durability with IFTNA’s PROTX2 antimicrobial finishes paired with ecoPEL fluorine-free water repellency or DryTX moisture management, and have been supported by peer-reviewed clinical trial data showing reduced bacterial contamination versus untreated scrubs. Management argues that the rapid expansion underscores pent-up demand among healthcare professionals for clinically validated medical textiles and strengthens iFabric’s position in the healthcare apparel segment, with products available both online and through the retailer’s growing store network.

The most recent analyst rating on (TSE:IFA) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on iFabric stock, see the TSE:IFA Stock Forecast page.

iFabric launches clinically validated Frontline antimicrobial scrubs at major Canadian wholesale club

iFabric’s subsidiary Intelligent Fabric Technologies (North America) has launched Frontline, a new line of medical scrubs at a major Canadian wholesale club, embedding its PROTX2 antimicrobial and ecoPEL water-repellent technologies. The move extends the company’s reach from specialty textile chemistry into finished consumer products sold via a large-scale, value-focused retail channel.

iFabric highlights that the Frontline scrubs are supported by peer-reviewed clinical evidence showing statistically significant reductions in bacterial contamination versus untreated garments in real healthcare settings. By pairing this validation with distribution on a national e-commerce platform that may later expand to stores and broader assortments, the company signals its capability to deliver end-to-end, clinically backed infection-control apparel programs at scale.

This is iFabric’s second major retail program where it oversees branding, design, development and manufacturing, underscoring its evolution into a full-scope partner for performance apparel. The launch reinforces its positioning to capitalize on rising healthcare demand for clinically validated antimicrobial solutions and could support further category expansion and market penetration across medical and performance apparel segments.

The most recent analyst rating on (TSE:IFA) stock is a Hold with a C$2.50 price target. To see the full list of analyst forecasts on iFabric stock, see the TSE:IFA Stock Forecast page.

iFabric Strikes Deal with The Lad Collective to Launch Functional Bedding in North America

iFabric’s subsidiary Intelligent Fabric Technologies (North America) Inc. has signed a licensing agreement with Australian bedding and sleep-essentials brand The Lad Collective to manufacture, market and distribute function-focused bedding products across North America. The partnership will combine The Lad Collective’s patented utility-led bedding features with iFabric’s advanced textile technologies, including its PROTX2 platform, to address what the companies see as a largely under-innovated bedding category and extend iFabric’s technology beyond apparel into home and bedding, potentially broadening its revenue base and strengthening its positioning in functional textiles.

The most recent analyst rating on (TSE:IFA) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on iFabric stock, see the TSE:IFA Stock Forecast page.

iFabric’s IFTNA Unit Launches Roots-Branded Footwear at Canadian Wholesale Club

iFabric’s subsidiary IFTNA has introduced a Roots-branded footwear line at a nationwide Canadian wholesale club, marking the company’s formal entry into footwear as a new finished-product category that showcases its proprietary performance technologies for comfort, wearability and freshness. The program is expected to generate about $8 million in incremental first-year revenue and builds on recent growth initiatives with major retailers like Walmart U.S. and Marks & Spencer, positioning iFabric to broaden its technology-enabled product offerings and expand its presence across lifestyle categories and global retail channels in 2026.

The most recent analyst rating on (TSE:IFA) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on iFabric stock, see the TSE:IFA Stock Forecast page.